KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Deferred Taxes (2019 - 2025)

GoodRx Holdings' Deferred Taxes history spans 7 years, with the latest figure at $12.0 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 206.3% year-over-year to $12.0 million; the TTM value through Dec 2025 reached $68000.0, up 100.57%, while the annual FY2025 figure was $20.1 million, 268.47% up from the prior year.
  • Deferred Taxes for Q4 2025 was $12.0 million at GoodRx Holdings, up from -$11.3 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $46.1 million in Q4 2021 and bottomed at -$63.0 million in Q2 2023.
  • The 5-year median for Deferred Taxes is -$182000.0 (2021), against an average of -$3.3 million.
  • The largest YoY upside for Deferred Taxes was 2459.49% in 2023 against a maximum downside of 108746.55% in 2023.
  • A 5-year view of Deferred Taxes shows it stood at $46.1 million in 2021, then plummeted by 100.77% to -$356000.0 in 2022, then soared by 1501.97% to $5.0 million in 2023, then crashed by 325.85% to -$11.3 million in 2024, then skyrocketed by 206.3% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Deferred Taxes are $12.0 million (Q4 2025), -$11.3 million (Q4 2024), and -$642000.0 (Q3 2024).